CorMedix CRMD
NASDAQ CRMD
$7.70 -0.23 (-2.90%)
At close: Sep 30, 2026 · 4:00 PM EDT

CorMedix (CRMD) EV to EBITDA (2025)

Updated

CorMedix's (CRMD) EV to EBITDA came in at 4.63 for Q4 2025, down 41.4% from the prior quarter.

Analysis

CorMedix (CRMD) EV to EBITDA (2025) Analysis & Trends

For FY2025, CorMedix's EV to EBITDA stood at 3.65.

  • According to Business Quant data, EV to EBITDA for the three prior quarters was 7.90 (Q3 2025), 14.60 (Q2 2025) and 22.77 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 CorMedix 615.90 Mn -36.62 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.63
Sep 30, 2025 7.90
Jun 30, 2025 14.60
Mar 31, 2025 22.77
API Access

CorMedix EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CRMD&period=max&api_key=YOUR_API_KEY